Kidney tubular β-catenin signaling controls interstitial fibroblast fate via epithelial-mesenchymal communication

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Zhou, Dong ^a   Tan, Roderick J ^a   Zhou, Lili ^a,b   Li, Yingjian ^a   Liu, Youhua ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; FAS LIGAND; MATRILYSIN;

ANIMAL; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CELL COMMUNICATION; CELL LINE; CELL SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM; FIBROBLAST; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; KIDNEY TUBULE; KNOCKOUT MOUSE; METABOLISM; MOUSE; MYOFIBROBLAST; PATHOLOGY; RAT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BETA CATENIN; CELL COMMUNICATION; CELL LINE; CELL SURVIVAL; EPITHELIAL-MESENCHYMAL TRANSITION; EPITHELIUM; FAS LIGAND PROTEIN; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; KIDNEY; KIDNEY TUBULES; MATRIX METALLOPROTEINASE 7; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MYOFIBROBLASTS; ORGAN SPECIFICITY; RATS; SIGNAL TRANSDUCTION;

EID: 84878694323     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01878     Document Type: Article

References (44)

1. Liu, Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7, 684-696 (2011).
2. Zeisberg, M. & Neilson, E. G. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21, 1819-1834 (2010).
3. Boor, P., Ostendorf, T. & Floege, J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 6, 643-656 (2010).
4. Iwano, M. et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110, 341-350 (2002). (Pubitemid 34847966)
5. Humphreys, B. D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176, 85-97 (2010).
6. Zeisberg, M. & Duffield, J. S. Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21, 1247-1253 (2010).
7. Grgic, I., Duffield, J. S. & Humphreys, B. D. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol 27, 183-193 (2012).
8. Strutz, F. How many different roads may a cell walk down in order to become a fibroblast? J Am Soc Nephrol 19, 2246-2248 (2008).
9. Herzog, E. L. & Bucala, R. Fibrocytes in health and disease. Exp Hematol 38, 548-556 (2010).
10. Clevers, H. & Nusse, R. Wnt/b-catenin signaling and disease. Cell 149, 1192-1205 (2012).
11. MacDonald, B. T., Tamai, K. & He, X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17, 9-26 (2009).
12. Angers, S. & Moon, R.T. Proximal events inWnt signaltransduction. NatRev Mol Cell Biol 10, 468-477 (2009).
13. Tan, R. J. & Liu, Y. Matrix metalloproteinases in kidney homeostasis and disease. Am J Physiol Renal Physiol 302, F1351-F1361 (2012).
14. Brabletz, T., Jung, A., Dag, S., Hlubek, F. & Kirchner, T. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155, 1033-1038 (1999). (Pubitemid 29488909)
15. McGuire, J. K., Li, Q. & Parks, W. C. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 162, 1831-1843 (2003). (Pubitemid 36613042)
16. Mitsiades, N., Yu, W. H., Poulaki, V., Tsokos, M. & Stamenkovic, I. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res 61, 577-581 (2001). (Pubitemid 32128617)
17. Li, M., Yamamoto, H., Adachi, Y., Maruyama, Y. & Shinomura, Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med 231, 20-27 (2006). (Pubitemid 43063974)
18. He, W. et al. Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/b-catenin activity in CKD. J Am Soc Nephrol 23, 294-304 (2012).
19. He, W. et al. Wnt/b-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20, 765-776 (2009).
20. von Toerne, C. et al. Wnt pathway regulation in chronic renal allograft damage. Am J Transplant 9, 2223-2239 (2009).
21. Nelson, P. J., von Toerne, C. & Grone, H. J. Wnt-signaling pathways in progressive renal fibrosis. Expert Opin Ther Targets 15, 1073-1083 (2011).
22. Dai, C. et al. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20, 1997-2008 (2009).
23. He, W., Kang, Y. S., Dai, C. & Liu, Y. Blockade of Wnt/b-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury in adriamycin nephropathy. J Am Soc Nephrol 22, 90-103 (2011).
24. Surendran, K., Schiavi, S. & Hruska, K. A. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol 16, 2373-2384 (2005). (Pubitemid 41725055)
25. Hao, S. et al. Targeted inhibition of b-catenin/CBP signaling ameliorates renal interstitial fibrosis. J. Am. Soc. Nephrol. 22, 1642-1653 (2011).
26. He, W. et al. Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/b-catenin signaling. J Biol Chem 285, 24665-24675 (2010).
27. Yang, J. & Liu, Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159, 1465-1475 (2001). (Pubitemid 32947976)
28. Liu, Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15, 1-12 (2004). (Pubitemid 38020692)
29. Zeisberg, M. & Neilson, E. G. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119, 1429-1437 (2009).
30. Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890 (2009).
31. Zhou, D. et al. Tubule-specific ablation of endogenous b-catenin aggravates acute kidney injury. Kidney Int 82, 537-547 (2012).
32. Wang, Z. et al. Beta-catenin promotes survival of renal epithelial cells by inhibiting Bax. J Am Soc Nephrol 20, 1919-1928 (2009).
33. Ehrenschwender, M. & Wajant, H. The role of FasL and Fas in health and disease. Adv Exp Med Biol 647, 64-93 (2009).
34. Villa-Morales, M. & Fernandez-Piqueras, J. Targeting the Fas/FasL signaling pathway in cancer therapy. Expert Opin Ther Targets 16, 85-101 (2012).
35. Liu, Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21, 212-222 (2010).
36. Quaggin, S. E. & Kapus, A. Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney Int 80, 41-50 (2011).
37. Wada, T. et al. Involvement of bone-marrow-derived cells in kidney fibrosis. Clin Exp Nephrol 15, 8-13 (2011).
38. Ding, H. et al. Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis. J Am Soc Nephrol 23, 801-813 (2012).
39. Surendran, K., Simon, T. C., Liapis, H. & McGuire, J. K. Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4. Kidney Int 65, 2212-2222 (2004). (Pubitemid 38670007)
40. Havasi, A. & Borkan, S. C. Apoptosis and acute kidney injury. Kidney Int 80, 29-40 (2011).
41. Jiang, M., Wang, C. Y., Huang, S., Yang, T. & Dong, Z. Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway. American Journal of Physiology-Renal Physiology 296, F983-993 (2009).
42. Wadsworth, S. J. et al. IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells. J Allergy Clin Immunol 126, 366-374 (2010).
43. Hu, K. et al. tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosis. J Am Soc Nephrol 19, 503-514 (2008). (Pubitemid 351355394)
44. Roucou, X., Antonsson, B. & Martinou, J. C. Involvement of mitochondria in apoptosis. Cardiol Clin 19, 45-55 (2001). (Pubitemid 32433915)